The Challenges that can be helped with a solid ADHD diagnosis

Webinar Transcript

Introduction and Speaker Backgrounds

Phil Anderton: Good evening, everyone, and welcome. My name is Phil Anderton, Managing Director of ADHD 360. I am delighted to be joined tonight by one of our senior clinicians, Rebecca Wheeland, who has an extensive clinical background, and Archie Reid, one of our patients and an employee of ADHD 360. Rebecca, would you like to introduce yourself to the participants?

Rebecca Wheeland: Good evening. My name is Rebecca Wheeland, Deputy Clinical Director at ADHD 360. I am a clinician with an extensive background in mental health psychiatry and as a specialist ADHD practitioner. As part of my clinical work, I oversee clinical standards within the organization while actively assessing and treating patients for ADHD.

Phil Anderton: Excellent. Archie, please introduce yourself.

Archie Reid: I’m Archie Reid. I’ve been a patient with ADHD 360 since starting my ADHD journey. I now work as part of the office team in our Sheffield office, supporting the work Rebecca and the clinical team do on a day-to-day basis.

Phil Anderton: Archie is a 21-year-old young man managing a degree while working almost full-time in our Sheffield office. He is a shining example of what a solid diagnosis and treatment plan can do to transform someone’s life. Rebecca, why did you decide to specialize in ADHD?

Rebecca Wheeland: I truly enjoy working with the ADHD patient population and community. Having an extensive history in mental health has set me in good stead to evaluate individuals holistically, considering ADHD alongside other aspects of their mental health presentation. Specializing in ADHD allows me to achieve clear, positive outcomes for patients, making the assessment, clinical intervention, and ongoing care deeply rewarding.

The Life-Changing Power of Insight and Diagnosis

Phil Anderton: Archie, what did getting a diagnosis do for you?

Archie Reid: Simply put, it changed my life. Before my diagnosis, I had just finished my GCSEs and had not achieved anywhere near my potential. I had no plans to go to university or even take A-levels. By chance, I overheard someone describe themselves as an “A-grade conversationalist but a C-grade student,” and I immediately identified with that statement. That kicked off my journey into exploring ADHD.

After receiving my diagnosis and starting treatment, I began my A-levels. My outlook completely shifted: I began enjoying school, engaging in class, and understanding the material. I was able to keep up with my peers and excel. That restored my self-confidence and self-belief, which had been on the floor after years of feeling inadequate. Now, I am studying for a business degree at Sheffield Hallam University while working part-time at ADHD 360—something I never thought possible previously.

Rebecca Wheeland: When managing patients with ADHD, we see clear pattern recognition. When symptoms are properly managed, the feedback is incredible. Patients describe how life becomes less of a battle across education, work, and relationships. Adults with undiagnosed ADHD often accumulate years of low-level negative feedback, which builds internal anxiety and self-doubt. Gaining insight into how ADHD causes these difficulties is the greatest asset because it empowers patients to understand their challenges rather than viewing them as personal failures.

Phil Anderton: Archie, how has gaining self-belief impacted your situational anxiety, particularly in academic and workplace environments?

Archie Reid: Previously, the constant fear of getting things wrong built up immense anxiety. I hated being called on in class because I felt I couldn’t process information properly. Once treatment allowed me to focus, listen, and keep up, that baseline anxiety significantly reduced. Before my diagnosis, my anxiety was so severe that I refused to answer phone calls from unknown numbers or speak up. Now, I can comfortably work in a professional environment alongside experienced colleagues and manage teams.

The Role of Non-Medical Support and Scaffolding

Phil Anderton: While medical treatment is vital, non-medical support and “scaffolding” play a crucial role. Archie, how does external support complement your treatment?

Archie Reid: Medication is fantastic, but it does not completely eliminate all ADHD traits, such as procrastination or morning inertia. To manage this, I rely on a support framework, particularly from my mother. For university assignments, I share deadlines with her so she can check in on my progress and help keep me accountable. In the morning, before my medication takes effect, I struggle to get out of bed, so she calls me to ensure I am up and preparing for the day. Embracing this support without shame has been essential to maintaining structure in my life.

Rebecca Wheeland: It is important to acknowledge that medication response varies by individual. While medication provides a foundation for symptom control, executive function strategies and external support systems remain necessary to address remaining challenges.

Phil Anderton: Archie, does medication completely resolve procrastination for you?

Archie Reid: No, it does not remove procrastination entirely. What it does is remove the initial paralysis. Before medication, I would write a few words or read a line and feel stuck, not knowing how to proceed. Medication gives me the cognitive clarity to structure a plan, process the steps required, and execute the task.

Clinical Principles of Medication Titration and Optimization

Phil Anderton: Rebecca, how do clinicians select the appropriate medication for a patient?

Rebecca Wheeland: We begin with a thorough evaluation of the patient’s medical history to determine which medications are safe. Under NICE guidelines, first-line treatment for adults consists of stimulant medications—either amphetamine-based (such as Elvanse or Amfexa) or methylphenidate-based (such as Concerta). Stimulants work by regulating dopamine and norepinephrine levels in the brain regions responsible for executive function.

When selecting a treatment, we consider the duration of symptom coverage required for the patient’s daily routine. The titration process involves finding the optimal balance between efficacy (improved focus, reduced impulsivity, better emotional regulation) and tolerability (monitoring side effects such as appetite suppression or elevated blood pressure/heart rate). If a patient does not respond to or tolerate one stimulant class, we switch to the other, or explore third-line non-stimulant options.

Phil Anderton: Archie, what was your personal medication journey like?

Archie Reid: Finding the right treatment involved trial and error. I initially started on Elvanse, which worked well for focus, but as it wore off in the evening, I experienced irritability. I then tried Concerta, but discovered I was a non-responder to methylphenidate. We then transitioned to Amfexa (dexamfetamine), an immediate-release medication taken three times daily, which has kept me stable and well-optimized.

Managing Co-Occurring ADHD and Autism (AuDHD)

Phil Anderton: Many individuals present with both ADHD and autism. Archie, how did treating your ADHD reveal underlying autistic traits?

Archie Reid: Prior to treatment, my ADHD symptoms were so dominant that they masked my autistic traits. Once medication quieted the cognitive noise of ADHD, my autistic tendencies—such as a strong need for routine, predictability, and clear planning—became much more noticeable. I had to learn to adapt to these needs, as unexpected changes to plans can still cause significant anxiety.

Rebecca Wheeland: This is a very common clinical occurrence. Once the executive dysfunction and restlessness of ADHD are managed, the underlying autistic need for structure, predictability, and routine comes to the forefront. Recognizing this allows us to help patients implement appropriate environmental and lifestyle adjustments alongside their medical treatment.

Addressing Self-Medication, Diet, and Healthy Lifestyle Choices

Phil Anderton: Many adults with undiagnosed ADHD engage in self-medication through caffeine or sugar. What was your experience with caffeine and diet, Archie?

Archie Reid: Before my diagnosis, I consumed multiple energy drinks daily just to get through school and cope with fatigue. When I started medical treatment, I eliminated caffeine entirely to protect my cardiovascular health and allow my clinician to clearly evaluate the medication’s true effect.

Regarding diet, untreated ADHD led to impulsive binge eating and reaching for convenience food due to executive difficulty in planning meals. Once treated, the impulsive eating stopped, allowing me to adopt healthier eating habits and achieve a stable weight.

Rebecca Wheeland: Untreated ADHD frequently manifests in dopamine-seeking behaviors like binge eating or reliance on high caffeine. Additionally, meal preparation requires complex executive planning, leading many to default to quick, processed choices. When ADHD is effectively treated, these behaviors often normalize. However, clinicians must carefully distinguish between symptom normalization and potential medication-induced appetite loss to ensure proper nutritional management.

Conclusion and Key Takeaways

Phil Anderton: Specialized clinical care makes a profound difference in guiding patients through assessment, titration, and long-term management. Rebecca, Archie, what are your final thoughts for anyone considering an ADHD evaluation?

Rebecca Wheeland: My advice is to seek help without delay if symptoms are impacting your life. Specialist ADHD care offers deep expertise to help you understand your unique profile and navigate treatment effectively.

Archie Reid: A solid diagnosis helps you truly understand yourself. Once you understand how your brain works, you can implement meaningful changes, access appropriate support, and begin living your best life.